What Bio Strategy Advisors does

Bio Strategy Advisors, LLC is a privately held strategic consulting firm founded in 2017 and based in Chestnut Hill, Massachusetts, serving small and medium-sized BioTech, MedTech, TechBio (AI), HealthTech, and SpaceTech companies. The firm delivers four principal service lines: Corporate Strategy (company formation, business planning, go-to-market strategy, financial modeling, IP strategy, and legal/transactional support), R&D Strategy and Support (IND gap analysis, pre-clinical and clinical development, regulatory and CMC strategy, FDA interaction), Investor-Readiness (pitch deck creation, practice pitch sessions, data room preparation), and Strategic Partnerships / Commercial Planning / Geographical Expansion (partnership identification, licensing, distribution, and market access).

The company does not develop or sell software products or proprietary technology platforms; its offering is senior-led advisory services delivered by a bench of experienced practitioners. The team includes founder Carolina Alarco (former VP at Genzyme, President at Aegerion Pharmaceuticals and Novelion Therapeutics) plus senior consultants with backgrounds at Roche/Genentech, Sanofi, Pfizer, Novartis, Bristol-Myers, Medtronic, Boston Scientific, Stryker, Hologic, and Zimmer Biomet. Revenue is generated through engagement-based, quote-based professional services fees, with GTM centered on direct engagement with founders/CEOs, community-led referral generation via board positions at MassBio, Mass General Hospital, and Latinos in Bio, and event-driven outreach including pitch practice sessions and webinars.

Customer concentration cannot be directly assessed from disclosed information. The firm states active or recent engagement across the US, EU, LATAM, Canada, Australia, Israel, MENA, and Japan/APAC, with particular emphasis on "soft-landing" advisory for ex-US startups seeking US investor-readiness and market entry. The 2025 selection into the AI Biohub Program Cohort at MIT's Lab Central (in collaboration with C10 Labs) and the extension of services into TechBio (AI) and SpaceTech verticals suggest an ongoing repositioning toward AI-adjacent life sciences advisory.

Name

Bio Strategy Advisors

Legal name

Bio Strategy Advisors, LLC

Website

https://biostrategyadvisors.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Bio Strategy Advisors is a privately held, founder-led boutique consulting firm based in Chestnut Hill, Massachusetts, providing strategic, R&D, investor-readiness, and commercial advisory services to small and medium-sized BioTech, MedTech, TechBio (AI), HealthTech, and SpaceTech companies, including soft-landing support for ex-US startups entering the US market.

Ownership category

akta.pro rank

Product category

Biotech Strategic Consulting

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Corporate Strategy Advisory (BPAHADAA)

akta.pro secondary industries

Strategy & Corporate Development Consulting (BPAHACAA), Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG), Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG)

Keywords

• Biotech strategic consulting
• Investor readiness advisory
• Go-to-market consulting
• Regulatory strategy services
• Medtech business advisory

Headquarters

HQ city

Chestnut Hill

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Strategic Consulting Services: Professional consulting fees for corporate strategy, R&D strategy, investor-readiness, and commercial planning services delivered to biotech, MedTech, and HealthTech companies. Engagement-based model serving both early-stage startups and later-stage companies.

Go-to-market motion3 records

Distribution channels1 record

Marketing channels4 records

Core offering

Bio Strategy Advisors is a strategic business consulting firm that delivers advisory engagements to small and medium-sized Biotech, MedTech, TechBio (AI), HealthTech and SpaceTech companies. Services span company formation, go-to-market strategy, R&D and regulatory support, investor-readiness preparation, strategic partnership identification/negotiation, and commercial planning with geographical expansion. Engagements are delivered directly by senior advisors to founders and CEOs.

Product overview

Bio Strategy Advisors is a strategic business consulting firm that offers a portfolio of advisory services for Biotech, MedTech, TechBio (AI), HealthTech and SpaceTech companies. The firm does not offer a unified software product or platform; instead, it delivers expert consulting services across four main domains: Corporate Strategy (company formation, business planning, go-to-market strategy, patent/IP strategy, pricing and market access, legal and transactional support), R&D Strategy and Support (IND gap analysis, pre-clinical and clinical development, regulatory strategy), Investor-Readiness (pitch deck creation, executive summary, data room preparation, practice pitch sessions), and Strategic Partnerships/Commercial Planning/Geographical Expansion (business opportunity sizing, launch planning, distribution and licensing deal structuring). Services are delivered by a team of seasoned professionals with deep domain expertise rather than through a software product.

Differentiator

Problem solved

Functional benefit

Products and services

• Corporate Strategy Advisory Strategic advisory for Biotech, TechBio, MedTech, HealthTech and SpaceTech companies covering company formation and incorporation, business plan and go-to-market strategy, 10-year financial models and P&L projections, structure building and workforce planning, patent and IP strategy, pricing and market access considerations, and legal & transactional support including founders agreements, board/employment/consulting agreements, equity incentive plans, NDAs and collaboration agreements. Includes US investor-readiness and soft-landing expertise for ex-US startups. Target buyers are founders and CEOs of small and medium-sized biotech and medtech companies.
• R&D Strategy and Support Strategic advice for Biotech and MedTech companies on R&D, Quality, Engineering, Manufacturing, Pharmacology, CMC and Regulatory matters. Covers IND gap analysis and IND-enabling studies roadmap, in-vitro and bench testing, pre-clinical and clinical development strategy and execution, and regulatory strategy and support for IND filing, FDA meetings and other regulatory affairs. Delivered by in-house regulatory and R&D experts. Target buyers are biotech and medtech founders/CEOs needing pre-clinical to clinical development and FDA strategy support.
• Investor-Readiness Advisory Advisory support to prepare biotech, medtech, TechBio, HealthTech and SpaceTech companies for Seed, Series A and Series B fundraising rounds. Services include pitch deck creation and polishing, executive summary preparation, data room preparation, and pitch practice sessions with Q&A simulating investor pitches and strategic partner presentations. Target buyers are early-stage startup founders and CEOs preparing for their first institutional fundraises.
• Strategic Partnerships, Commercial Planning and Geographical Expansion Advisory for later-stage biotech and medtech companies covering strategic partnerships identification of targets, outreach, business approach, negotiation, structuring and closing of co-development, licensing or strategic transactions; commercial planning, go-to-market models, geographical expansion, licensing and full-service distribution deals, patient advocacy, market access and product launch strategy; and identification of full-service distributors or licensees in geographies including Europe, Canada, Australia, LATAM, Israel, MENA and Japan/APAC. Target buyers are later-stage biotech and medtech CEOs and business development leaders.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Twelve partnerships are on record, tiered core and minor.

• MassBio (Massachusetts Biotechnology Council)coreOthersFounder Carolina Alarco serves on the Board of MassBio, providing visibility and credibility within the Massachusetts biotech ecosystem. This affiliation positions Bio Strategy Advisors within the premier biotech industry association in the region.
• Latinos in BiocoreOthersFounder Carolina Alarco co-founded Latinos in Bio and serves as co-chair. Team member Fernanda Gamero serves as Marketing Specialist for this 501(c)(3) non-profit with over 1,200 members dedicated to amplifying social capital of Latino/a professionals in BioPharma and Life Sciences.
• Mass General Hospital Board of Trustees (MGPO)minorOthersFounder serves on the Mass General Hospital Board of Trustees, providing connections to one of the world's leading healthcare institutions.
• Eastern BankminorOthersFounder serves on the Board of Advisors of Eastern Bank, a publicly traded bank in Boston, providing potential banking and financial services connections.
• Informa Connect (Cell and Gene Therapy Advisory Board)minorOthersFounder serves as Advisory Board Member for Cell and Gene Therapy at Informa Connect, a leading events and publishing company serving the life sciences industry.
• Syte.biominorStrategic or Co-development PartnerStrategic consultant Martin Williams is CEO & Founder of SYTE.bio, a biotech startup with next-generation nucleic acid-based technologies. This represents an internal company relationship within the BSA ecosystem.
• Healix InstrumentsminorStrategic or Co-development PartnerStrategic consultant Martin Williams has also founded Healix Instruments, a medical device company. This represents an internal company relationship within the BSA ecosystem.
• SpectrusminorStrategic or Co-development PartnerVeronica Gibaja serves as advisor to Spectrus on integration of cellular assays with proteomics, metabolomics, and glycomics to accelerate drug discovery and partnering efforts.
• Mass Innovation NetworkminorOthersVeronica Gibaja mentors startups through Mass Innovation Network programs, supporting early-stage company development.
• BrightEdge (American Cancer Society Venture)minorOthersVeronica Gibaja mentors startups through BrightEdge, the venture arm of the American Cancer Society.
• NucleateminorOthersVeronica Gibaja mentors startups through Nucleate, an organization supporting biotech startup formation.
• Multiomics Inc.minorStrategic or Co-development PartnerAstrid Margossian serves as CEO/CMO of Multiomics Inc., developing an AI-driven ultrasensitive liquid biopsy for solid cancers at MIT's Lab Central. This represents an internal company relationship within the BSA ecosystem.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Trinity Life Sciences: Trinity Life Sciences is a large life sciences strategy consulting firm that advises biopharma and medtech clients on commercial strategy, R&D, and market access. It is directly comparable to BSA in the same client verticals and service categories (corporate strategy, R&D strategy, strategic partnerships), but operates at a much larger scale.
• Health Advances: Health Advances is a life sciences-focused strategy consulting firm advising biotech, medtech, and diagnostics companies on corporate strategy, R&D, and commercialization. Highly comparable to BSA in service mix, client verticals, and boutique positioning in the Boston/Northeast life sciences ecosystem.
• ClearView Healthcare Partners: ClearView Healthcare Partners is a boutique strategy consulting firm serving biopharmaceutical, medical device, and diagnostics clients across corporate, R&D, and commercial strategy. Overlaps directly with BSA's core offerings and client base, with a similar operator-leaning positioning.
• Locust Walk: Locust Walk is a life sciences-focused transaction and strategic advisory firm that supports biotech and medtech companies with capital raising, strategic partnerships, and M&A. Directly comparable to BSA's investor-readiness and strategic partnerships offerings, with similar client vertical focus.
• Back Bay Life Science Advisors: Back Bay Life Science Advisors is a Boston-based life sciences advisory firm providing strategic and transactional advice to biotech and medtech companies. Closely comparable in geography, client verticals, and service mix — particularly strategic partnerships, capital raising, and corporate strategy.
• Lumanity: Lumanity is a life sciences advisory and consulting firm formed from the integration of several life sciences consultancies, serving biopharma across strategy, R&D, and commercial decisions. Comparable in service breadth and client base, though significantly larger and broader than BSA.
• Alacrita Consulting: Alacrita is a boutique life sciences consulting firm advising biotech and pharma companies on commercial strategy, R&D, and corporate development. Highly comparable in boutique positioning and biotech/medtech client focus, though broader in therapeutic-area coverage.

Broad incumbents

• ZS Associates: ZS Associates is a large global consulting firm with a deep life sciences practice spanning strategy, R&D, and commercial/sales/marketing operations. Comparable to BSA on life sciences strategy and pricing/market access, but operates at significantly larger scale with broader service lines.
• L.E.K. Consulting: L.E.K. Consulting is a global strategy consulting firm with a sizable life sciences practice covering biotech, medtech, and pharma strategy and M&A. Overlaps with BSA in biopharma strategy and partnerships advisory, but at substantially greater scale and geographic reach.
• Simon-Kucher & Partners: Simon-Kucher is a global consulting firm specializing in pricing, market access, and commercial strategy with a strong life sciences vertical. Comparable to BSA's pricing and market access offerings (Pablo Medina's specialty) and commercial planning services, but at much larger scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bio-strategy-advisors-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bio Strategy Advisors